The role of adjuvant chemotherapy in locally advanced bladder cancer

References

• Howlander N, Noone AM, Krapcho M, et al. Seer cancer statistics review, 1975–2009 (vintage 2009 populations). Bethesda (MD): National Cancer Institute; 2012.
   Google Scholar
• Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists. Lancet. 1999;354:533–540.
   PubMed Web of Science ®Google Scholar
• Griffiths G, Hall R, Sylvester R, et al. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the ba06 30894 trial. J Clin Oncol. 2011;29:2171–2177.
   PubMed Web of Science ®Google Scholar
• Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003;349:859–866.
   PubMed Web of Science ®Google Scholar
• Collaboration ABCM-a. Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet. 2003;361:1927–1934.
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network [Internet]. Bladder Cancer. Version 5.2017; 2017. Available from: https://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf
   Google Scholar
• Feifer A, Taylor JM, Shouery M, et al. Multi-institutional quality-of-care initiative for nonmetastatic, muscle-invasive, transitional cell carcinoma of the bladder: phase I. J Clin Oncol. 2011;29:240–240.
   Web of Science ®Google Scholar
• Raghavan D, Bawtinhimer A, Mahoney J, et al. Adjuvant chemotherapy for bladder cancer-why does level 1 evidence not support it? Ann Oncol. 2014;25:1930–1934.
   PubMed Web of Science ®Google Scholar
• Yafi FA, Aprikian AG, Chin JL, et al. Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a canadian multicentre experience. BJU Int. 2011;108:539–545.
   PubMed Web of Science ®Google Scholar
• Bilimoria KY, Stewart AK, Winchester DP, et al. The national cancer data base: a powerful initiative to improve cancer care in the united states. Ann Surg Oncol. 2008;15:683–690.
   PubMed Web of Science ®Google Scholar
• Haque W, Verma V, Butler EB, et al. Patterns of care and outcomes of multi-agent versus single-agent chemotherapy as part of multimodal management of low grade glioma. J Neurooncol. 2017;133:369–375.
   PubMed Web of Science ®Google Scholar
• Haque W, Verma V, Fakhreddine M, et al. Addition of chemotherapy to definitive radiotherapy for IB1 and IIA1 cervical cancer: analysis of the national cancer data base. Gynecol Oncol. 2017;144:28–33.
   PubMed Web of Science ®Google Scholar
• Brower JV, Chen S, Bassetti MF, et al. Radiation dose escalation in esophageal cancer revisited: a contemporary analysis of the national cancer data base, 2004 to 2012. Int J Radiat Oncol Biol Phys. 2016;96:985–993.
   PubMed Web of Science ®Google Scholar
• Zargar-Shoshtari K, Kongnyuy M, Sharma P, et al. Clinical role of additional adjuvant chemotherapy in patients with locally advanced urothelial carcinoma following neoadjuvant chemotherapy and cystectomy. World J Urol. 2016;34:1567–1573.
   PubMed Web of Science ®Google Scholar
• Freiha F, Reese J, Torti FM. A randomized trial of radical cystectomy plus cisplatin, vinblastine, and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol. 1996;155:495–500.
   PubMed Web of Science ®Google Scholar
• Cognetti F, Ruggeri FM, Felici A, et al. Adjvuant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian multicenter, randomized phase III trial. Ann Oncol. 2012;23:695–700.
   PubMed Web of Science ®Google Scholar
• Haque W, Verma V, Butler EB, et al. National practice patterns and outcomes for T4b urothelial cancer of the bladder. Clin Genitourin Cancer. 2017;S1558–7673:30268–30269.
   PubMed Web of Science ®Google Scholar
• Verma V, McMillan MT, Grover S, et al. Stereotactic body radiation therapy and the influence of chemotherapy on overall survival for large (≥5 centimeter) non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2017;97:146–154.
   PubMed Web of Science ®Google Scholar
• Christodouleas JP, Hwang WT, Baumann BC. Adjuvant radiation for locally advanced bladder cancer? A question worth askin. Int J Radiat Oncol Biol Phys. 2016;94:1040–1042.
   PubMed Web of Science ®Google Scholar
• Reddy AV, Pariser JJ, Pearce SM, et al. Patterns of failure after radical cystectomy for pT3-4 bladder cancer: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys. 2016;95:703–706.
   PubMed Web of Science ®Google Scholar